SEARCH
Covaxin: দুই থেকে আঠেরোর জন্য কোভ্যাক্সিনের ক্লিনিকাল ট্রায়ালে ছাড়পত্র
LatestLY Bangla
2021-05-19
Views
48
Description
Share / Embed
Download This Video
Report
শিশুদের ক্ষেত্রে ভারত বায়োটেকের কোভ্যাক্সিন প্রয়োগ করা যাবে কি না, এবার সে বিষয়ে ক্লিনিকাল ট্রায়াল শুরু হচ্ছে ৷ ড্রাগ কন্ট্রোলার জেনারেল অফ ইন্ডিয়া এর তরফে দেওয়া হয়েছে ছাড়পত্র৷
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x81d3te" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By The Drugs Controller General Of India (DCGI)
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGI
01:41
Covid Guidelines For School Reopening Updated: VK Paul, NITI Aayog
00:45
Amid Omicron threat, Niti Aayog member Dr VK Paul says COVID-19 vaccines may become ineffective
00:52
Two doses of Covid vaccine provide 98% protection against death_ VK Paul, Niti Aayog, Member-Health
01:35
Bharat Biotech Submits Covaxin Phase-III Clinical Trial Data To DCGI
03:59
Covishield of Serum Institute,Covaxin of Bharat Biotech get DCGI approval as coronavirus vaccines_D4-H-21
04:48
Health Ministry & NITI Aayog On Covishield-Covaxin Vaccine Mix-Up In Uttar Pradesh; ‘Significant Effect Unlikely If Doses Mixed,’ Says Centre
02:37
Covishield To Be Continued As Two-Dose Vaccine Says VK Paul, NITI Aayog
02:17
VK Saraswat, NITI Aayog Member Says, ‘Internet Used In J&K For Dirty Films; Apologises Later
02:14
NITI Aayog सदस्य VK Saraswat का विवादित बयान- Dirty Movies देखते हैं Kashmir के लोग | वनइंडिया हिंदी
01:06
Niti Aayog member VK Saraswat says Kashmiris have no use of internet | OneIndia News